Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism
Open accessAbstract
Alzheimer’s disease (AD) is a neurodegenerative disease that causes late-onset dementia. The R47H variant of the microglial receptor TREM2 triples AD risk in genome-wide association studies. In mouse AD models, TREM2-deficient microglia fail to proliferate and cluster around the amyloid-β plaques characteristic of AD. In vitro, the common variant (CV) of TREM2 binds anionic lipids, whereas R47H mutation impairs binding. However, in vivo, the identity of TREM2 ligands and effect of the R47H variant remain unknown. We generated transgenic mice expressing human CV or R47H TREM2 and lacking endogenous TREM2 in the 5XFAD AD model. Only the CV transgene restored amyloid-β–induced microgliosis and microglial activation, indicating that R47H impairs TREM2 function in vivo. Remarkably, soluble TREM2 was found on neurons and plaques in CV- but not R47H-expressing 5XFAD brains, although in vitro CV and R47H were shed similarly via Adam17 proteolytic activity. These results demonstrate that TREM2 interacts with neurons and plaques duing amyloid-β accumulation and R47H impairs this interaction.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mice carrying R47H variation display impaired binding of TREM2 with anionic and zwitterionic lipids known to associate with fibrillar Aβ, leading to failure of microglia to cluster around Aβ plaques, apoptosis, augmented Aβ accumulation, and spread of neuritic plaque tau aggregates.
“Mice carrying R47H variation displayed impaired binding of TREM2 with anionic and zwitterionic lipids which are known to associate with fibrillar Aβ. As a result, microglia failed to cluster around Aβ plaques and became apoptotic, subsequently leading to augmented Aβ accumulation,198,199 and spread of neuritic plaque tau aggregates.200”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [199]
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredLoss of TREM2 function in Alzheimer's disease mouse models limits microglial plaque surrounding, proliferation, and conversion to disease-associated microglia, leading to more severe neuritic dystrophy.
“loss of TREM2 function in AD mouse models restricts the ability of microglia to surround Aβ plaques15,16, proliferate, and convert to DAM10,15,17, which in turn leads to more profound neuritic dystrophy18,19.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [17]
In mouse models of Alzheimer's disease, the disease-associated microglia program depends on TREM2.
“activation of “disease-associated microglia” (DAM) is dependent on TREM2 in mouse models of AD.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [17]
sTREM2 directly binds to neurons in mouse models of AD and inhibits LTP induction.
“experimental evidence revealed that sTREM2 directly bound to neurons in mouse models of AD194 and inhibited LTP induction.”
From Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets (2023) · cites this paper as [194]
Aβ-induced microglial activation is impaired in humanized transgenic mice expressing human R47H TREM2, and the R47H mutation impairs TREM2 binding to anionic lipids.
“Aβ-induced microglial activation is impaired in humanized transgenic mice expressing human R47H TREM2 (REF.169), and the R47H mutation impairs TREM2 binding to anionic lipids166.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [169]
Other studies have not revealed obvious phenotypes in young Trem2 R47H expressing mice, or even Trem2 knockout mice, unless they are aged or bred to amyloid mouse models.
“Other studies have not revealed obvious phenotypes in young Trem2 R47H expressing mice, or even Trem2 knockout mice, unless they are aged or bred to amyloid mouse models (35,61,85–87).”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [85]
Impaired or absent Trem2 function attenuates the microglial response to amyloid pathology by regulating microglial number around plaques, regulating microglial activity, and restricting neuritic damage.
“Recent important studies have also shown that impaired/absent Trem2 function attenuates the microglial response to amyloid pathology by regulating microglial number around plaques, regulating microglial activity, and restricting neuritic damage (37,61,84–87,95–99).”
From <i>Trem2</i> promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions (2020) · cites this paper as [85]
Data from human genetics, particularly with respect to the hypomorphic R47H allele of TREM2 that strongly increases risk for AD, provide strong evidence for a protective role for microglia.
“Data from human genetics, particularly with respect to the hypomorphic R47H allele of TREM2 that strongly increases risk for AD (32, 33, 102), provide strong evidence for a protective role for microglia.”
From The Transcriptional Landscape of Microglial Genes in Aging and Neurodegenerative Disease (2019) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 50 · Cited by 305
Research works printed but not linked: 1
- Korvatska O., Leverenz J.B., Jayadev S., McMillan P., Kurtz I., Guo X., Rumbaugh M., Matsushita M., Girirajan S., Dorschner M.O., 2015 R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study. JAMA Neurol. 72: 920– 927. 10.1001/jamaneurol.2015.0979 26076170 PMC4825672 · DOI · Paper page
- Authors
- Song, W. M., Joshita, S., Zhou, Y., Ulland, T. K., Gilfillan, S., & Colonna, M.
- Affiliations
- Washington University in St. Louis (US)
- Shinshu University (JP)
- Corresponding author
- Colonna, Marco
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2018-01-10
- Volume
- 215
- Issue
- 3
- Pages
- 745-760
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5839761
- OpenAlex
- W2784206224
- Cited by
- 305
- References
- 50
- Citations by year
- 2026: 27 · 2025: 35 · 2024: 31 · 2023: 58 · 2022: 23 · 2021: 38 · 2020: 26 · 2019: 33 · 2018: 33
- FWCI
- 14.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion)
- Funders
- National Cancer Institute (P30 CA91842)
- Institute of Clinical and Translational Sciences
- Clinical and Translational Science Awards
- National Center for Research Resources (UL1TR000448)
- National Institutes of Health
- Washington University School of Medicine in St. Louis
- Children’s Discovery Institute of Washington University
- St. Louis Children’s Hospital (CDI-CORE-2015-505)
- National Institute for Neurological Disorders and Stroke (NS086741)
- NIH (5T32CA009547-30, P30DK052574, P30DK020579, RF1 AG05148501)
- Cure Alzheimer’s Fund
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- TREM2, Alzheimer's disease, microglia, amyloid plaques, microglial activation, soluble TREM2, microglia-neuron interaction, 5xFAD mice
- MeSH terms
- ADAM17 Protein, Animals, Brain, Cell Count, Gliosis, Humans, Membrane Glycoproteins, Mice, Transgenic, Neurons, Receptors, Immunologic, Solubility, Microglia, Polymorphism, Single Nucleotide, Myeloid Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review